Breaking News

Halo Invests in Altus

First step in offering formulation and delivery solutions

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Halo Pharma has taken a minority ownership position in the drug formulation and development company Altus Formulation Inc. Altus uses proprietary technologies and approaches to solve pharmaceutical formulation and delivery problems. The companies have established a formal collaboration in conjunction with the investment. Halo has been focused on development and manufacturing services, and will continue to offer “practical facilitation and implementation of non-proprietary and client-based...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters